Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The Journal of Rheumatology|November 1, 2025
Anifrolumab Therapy in Dermatomyositis: New Insights From Refractory PatientsLinda Carli, Lorenzo Cavagna, Chiara Cardelli, et al.Clinical and Experimental Rheumatology|February 5, 2025
Environmental triggers for idiopathic inflammatory myopathies: unravelling the known and unknownChiara Cardelli, Francesca Trentin, Federico Fattorini, et al.Journal of Personalized Medicine|March 27, 2026
The Role of Ultrasound Pleural Irregularities in the Identification of Interstitial Lung Disease in Idiopathic Inflammatory MyopathiesLinda Carli, Simone Barsotti, Chiara Romei, et al.RMD Open|December 9, 2021
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodiesChiara Tani, Federico Pratesi, Rosaria Talarico, et al.Clinical Rheumatology|December 22, 2023
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-ItalyFrancesco D'Alessandro, Massimiliano Cazzato, Elenia Laurino, et al.Journal of Personalized Medicine|September 28, 2023
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical PracticeMaurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.Journal of Clinical Medicine|November 9, 2024
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and DifferencesAndreina Manfredi, Vincenzo Venerito, Massimiliano Cazzato, et al.Journal of Clinical Medicine|November 25, 2023
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian StudyMarco Sebastiani, Vincenzo Venerito, Elenia Laurino, et al.Pageof 1